STRATA Skin Sciences Inc SSKN.OQ SSKN.O is expected to show a fall in quarterly revenue when it reports results on November 13 for the period ending September 30 2024
The Horsham Pennsylvania-based company is expected to report a 3.6% decrease in revenue to $8.536 million from $8.85 million a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for STRATA Skin Sciences Inc is for a loss of 44 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for STRATA Skin Sciences Inc is 16.00, above its last closing price of $3.08.
This summary was machine generated November 12 at 03:46 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)